A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...
Dr. Maluf emphasized that his discussion would focus on penile squamous cell carcinoma and genitourinary basket trials. At ASCO 2024, Dr. Maluf presented the HERCULES (LACOG 0218), a phase II trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results